Abstract

A detannified methanolic extract of Scrophularia lucida L. attenuated the formation of cancer cell-induced circular chemorepellent induced defects (CCIDs) in the lymph endothelial cell barrier, which resemble entry ports for the intravasating tumor into the vasculature as a prerequisite for lymph node metastasis. Therefore, the composition of this extract was studied in an activity-guided approach. Since no data on the secondary metabolites of this plant were available, first phytochemical data were collected in the course of the fractionation of the extract. The study resulted in the identification of 14 substances, among them very rare iridoids, such as scrovalentinoside or koelzioside, and several flavonoids (e.g., nepitrin and homoplantaginin). One of the latter group, 2″-O-acetyl-homoplantaginin, is a new natural compound. In the most active fraction, the flavonoid hispidulin was identified as major component and the assay of the pure compound confirmed a contribution of hispidulin to the CCID-inhibitory effects of S. lucida. The activity of the two major iridoids in this assay was less compared to hispidulin.

Highlights

  • Species of the genus Scrophularia have been applied for centuries in traditional medicine

  • After subsequent partition with chloroform and ethyl acetate, the two organic fractions and the residue of the aqueous phase were tested in the circular chemorepellent induced defects (CCIDs) assay

  • Was chosen for further separation by column chromatography (CC) on silica and five of the resulting sub-fractions (A–E) were active in the CCID assay with sub-fraction A exhibiting the strongest inhibition (Figure 2)

Read more

Summary

Introduction

Species of the genus Scrophularia have been applied for centuries in traditional medicine. A detannified methanolic extract of S. lucida L. was the most active one in suppressing CCID formation (Giessrigl et al, 2012). In fractions k and l, compound 1 was identified by TLC and LC-DAD.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.